Serial life sciences entrepreneur Dr Stephen Little honoured at 16th Annual Bionow Awards

From Drug Discovery Today - December 6, 2017

Dr Little, who led Manchester-based Premaitha through its successful AIM listing in July 2014, has an impressive track record of building biotech businesses and creating value.


He is the former CEO of DxS, an innovator in the field of personalised medicine, developing and manufacturing companion diagnostics. DxS was funded with 3.5m in 2001 and was sold to QIAGEN in 2009 for 85m. Before DxS, Dr Little worked for 20 years in various senior positions in the diagnostic divisions of AstraZeneca and ICI. He holds a PhD from Heriot-Watt University in Edinburgh.

Celebrating the outstanding leaders and innovators in the life sciences sector in the North of England, the Bionow awards ceremony was attended by more than 400 people at the Mere Golf Resort and Spa in Cheshire.

In the highly sought-after Company of the Year category, Keele Science Park-based Cobra Biologics was triumphant. Cobra, an international contract development and manufacturer of biologics and pharmaceuticals, is in the midst of a 15m expansion programme in the UK and Sweden. The company, which manufactures DNA and viral vectors for the gene therapy market, exports 98% of its products.

A 700,000 fundraising by University of Manchester spin-out company Microbiosensor, which develops disposable point-of-care medical devices, was named Investment Deal of the Year, while Peter Chater a research associate at the University of Newcastle won in the prestigious Promising Technologist of the Year category.

The awards, which recognise excellence, outstanding achievement and enterprise in a sector that is worth 11bn to the Norths economy, were sponsored by Manchester Science Partnerships, Appleyard Lees and World Courier.

The full list of winners was:

Bionow Start Up of the Year Award (Sponsored by RSM)
ApconiX

Bionow Healthcare Project of the Year Award (Sponsored by TRUSTECH)
Sky Medical Technology / James Cook University Hospital South Tees NHS Trust -
Reducing the time to surgery for ankle fracture patients.

Continue reading at Drug Discovery Today »